Systemic Solutions in Retinopathy of Prematurity.
Related Articles |
Systemic Solutions in Retinopathy of Prematurity.
Am J Ophthalmol. 2018 May 21;:
Authors: Moshfeghi DM
Abstract
PURPOSE: To describe a framework for screening and treatment of retinopathy of prematurity using telemedicine screening with laser and/or vascular endothelial growth factor inhibitor treatment strategies.
DESIGN: Literature review and perspective METHODS: Review of the literature and the author's experience RESULTS: Undetermined CONCLUSIONS: Telemedicine can be deployed on a national basis to provide quaternary level screening for ROP. At-risk patients for treatment could then be directed to receive either laser photocoagulation or vascular endothelial growth factor inhibitor intravitreal injections followed at a later time point by examination under anesthesia, fluorescein angiography, and diode laser photocoagulation as indicated.
PMID: 29792838 [PubMed - as supplied by publisher]
Powered by WPeMatico
Sede Legale
Viale Campi Flegrei 55
80124 - Napoli
Sede Operativa
Via G.Porzio 4
Centro Direzionale G1
80143 - Napoli